Hans R Brunner - JoVE Visualize

Showing results (11-20 of 42) with videos related to

Pageof 5

Sort By:

Journal of Hypertension|October 11, 2013

Aldosterone synthase inhibition for the treatment of hypertension and the derived mechanistic requirements for a new therapeutic strategyChristoph D Schumacher, Ronald E Steele, Hans R Brunner

Hypertension (Dallas, Tex. : 1979)|January 19, 2002

Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalaprilJuerg Nussberger, Grégoire Wuerzner, Chris Jensen, et al.

Pharmacological Reviews|March 15, 2013

A systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonistsMartin C Michel, Carolyn Foster, Hans R Brunner, et al.

Pharmacology & Therapeutics|May 1, 2016

Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal diseaseMartin C Michel, Hans R Brunner, Carolyn Foster, et al.

Hypertension (Dallas, Tex. : 1979)|January 4, 2003

Angiotensin II receptor blockade: is there truly a benefit of adding an ACE inhibitor?Andrei Forclaz, Marc Maillard, Jürg Nussberger, et al.

Journal of Neurochemistry|June 18, 2002

Dibasic cleavage site is required for sorting to the regulated secretory pathway for both pro- and neuropeptide YNoureddine Brakch, Flore Allemandou, Claudia Cavadas, et al.

Hypertension (Dallas, Tex. : 1979)|September 7, 2002

Renal hemodynamic and natriuretic effects of concomitant Angiotensin-converting enzyme and neutral endopeptidase inhibition in menFrédéric Regamey, Marc Maillard, Jürg Nussberger, et al.

Clinical Pharmacokinetics|March 13, 2002

Population pharmacokinetic-pharmacodynamic modelling of angiotensin receptor blockade in healthy volunteersChantal Csajka, Thierry Buclin, Karin Fattinger, et al.

Kidney International|February 19, 2002

Renal segmental tubular response to salt during the normal menstrual cycleAntoinette Pechère-Bertschi, Marc Maillard, Hans Stalder, et al.

Biorheology|November 28, 2002

ET-1 and NOS III gene expression regulation by plaque-free and plaque-prone hemodynamic conditionsMélanie Mattart, Lucia Mazzolai, Céline Chambaz, et al.

Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:

Pageof 5

Journal of Hypertension|October 11, 2013

Aldosterone synthase inhibition for the treatment of hypertension and the derived mechanistic requirements for a new therapeutic strategyChristoph D Schumacher, Ronald E Steele, Hans R Brunner

Hypertension (Dallas, Tex. : 1979)|January 19, 2002

Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalaprilJuerg Nussberger, Grégoire Wuerzner, Chris Jensen, et al.

Pharmacological Reviews|March 15, 2013

A systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonistsMartin C Michel, Carolyn Foster, Hans R Brunner, et al.

Pharmacology & Therapeutics|May 1, 2016

Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal diseaseMartin C Michel, Hans R Brunner, Carolyn Foster, et al.

Hypertension (Dallas, Tex. : 1979)|January 4, 2003

Angiotensin II receptor blockade: is there truly a benefit of adding an ACE inhibitor?Andrei Forclaz, Marc Maillard, Jürg Nussberger, et al.

Journal of Neurochemistry|June 18, 2002

Dibasic cleavage site is required for sorting to the regulated secretory pathway for both pro- and neuropeptide YNoureddine Brakch, Flore Allemandou, Claudia Cavadas, et al.

Hypertension (Dallas, Tex. : 1979)|September 7, 2002

Renal hemodynamic and natriuretic effects of concomitant Angiotensin-converting enzyme and neutral endopeptidase inhibition in menFrédéric Regamey, Marc Maillard, Jürg Nussberger, et al.

Clinical Pharmacokinetics|March 13, 2002

Population pharmacokinetic-pharmacodynamic modelling of angiotensin receptor blockade in healthy volunteersChantal Csajka, Thierry Buclin, Karin Fattinger, et al.

Kidney International|February 19, 2002

Renal segmental tubular response to salt during the normal menstrual cycleAntoinette Pechère-Bertschi, Marc Maillard, Hans Stalder, et al.

Biorheology|November 28, 2002

ET-1 and NOS III gene expression regulation by plaque-free and plaque-prone hemodynamic conditionsMélanie Mattart, Lucia Mazzolai, Céline Chambaz, et al.

Pageof 5